Villar Jesús, Flores Carlos, Méndez-Alvarez Sebastián
Research Institute, Hospital Universitario N.S. de Candelaria, Tenerife, Canary Islands, Spain.
Crit Care Med. 2003 Apr;31(4 Suppl):S272-5. doi: 10.1097/01.CCM.0000057903.11528.6D.
To review the complex interactions of markers of genetic susceptibility for critical illness and acute lung injury. These may affect the responses of critically ill patients to acute lung injury and acute respiratory distress syndrome and may affect outcome.
Published research and review articles related to genetic factors associated with susceptibility to critical illnesses and pulmonary disease.
Critical illness in adults often is followed by acute lung injury, a phenomenon of acute diffuse lung inflammation. Physicians have long known that each patient responds differently to drugs and has a different risk for a particular event or outcome. Now, there is some evidence that cellular and humoral immune responses are subject to polymorphic genetic control, which explains the well-known diversity of clinical manifestations and outcomes in critically ill patients with the same disease. By revealing altered expression of relatively few genes involved in the responses to lung injury and repair, some investigators have found that these responses, and susceptibility to acute lung injury, are heritable. In the last 5 yrs, we have discovered that an individual's risks and cellular responses can be related to his or her own unique DNA.
The search for an association between functional variants of a gene and clinical phenotype may help to identify key pathophysiological processes of disease. In the future, we will know much about which therapy is best for each individual patient in the intensive care unit.
综述危重症和急性肺损伤遗传易感性标志物的复杂相互作用。这些相互作用可能影响危重症患者对急性肺损伤和急性呼吸窘迫综合征的反应,并可能影响预后。
与危重症和肺部疾病易感性相关的遗传因素的已发表研究和综述文章。
成人危重症常继发急性肺损伤,这是一种急性弥漫性肺炎症现象。医生早就知道,每个患者对药物的反应不同,发生特定事件或出现特定结果的风险也不同。现在,有证据表明细胞和体液免疫反应受多态性基因控制,这解释了患有相同疾病的危重症患者临床表现和预后的众所周知的多样性。通过揭示参与肺损伤和修复反应的相对较少基因的表达改变,一些研究人员发现这些反应以及对急性肺损伤的易感性是可遗传的。在过去5年里,我们发现个体的风险和细胞反应可能与其自身独特的DNA有关。
寻找基因功能变异与临床表型之间的关联可能有助于识别疾病的关键病理生理过程。未来,我们将更多地了解哪种治疗方法最适合重症监护病房的每个患者。